The weekly litigation news digest is live. Subscribe now

Pharmaceutical Composition Containing An Anti-Nucleating Agent - EP3165220

The patent EP3165220 was granted to Merck Sharp & Dohme on Nov 13, 2024. The application was originally filed on Dec 2, 2005 under application number EP16198994A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3165220

MERCK SHARP & DOHME
Application Number
EP16198994A
Filing Date
Dec 2, 2005
Status
Patent Maintained As Amended
Oct 11, 2024
Publication Date
Nov 13, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBJan 3, 2020-ADMISSIBLE
KRAUS & LEDERER PARTGMBBDec 17, 2019KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO03035077
OPPOSITIONEP1904067
OPPOSITIONWO03035077
OPPOSITIONWO03086319
OPPOSITIONWO2006060681
OPPOSITIONWO2006060730
OPPOSITIONWO2012147101
SEARCHUS2004002485
SEARCHUS6369094
SEARCHWO0185700
SEARCHWO03035077
SEARCHWO2006060711
SEARCHWO2006060712

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents